Main public logs
Jump to navigation
Jump to search
Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 10:09, 29 March 2024 Fire talk contribs created page Category:Nitrogen cycle (Created page with "{{Commons category|Nitrogen metabolism}} {{Cat more|Nitrogen cycle}} Nitrogen is a critical chemical element in both proteins and nucleic acids, and thus every living organism must metabolize nitrogen to survive. Only bacteria and Archaea are able to convert nitrogen gas (N<sub>2</sub>) to and from soluble ionic compounds that other organisms can metabolize. Metabolism, Nitrogen N Category:E...")
- 10:08, 29 March 2024 Fire talk contribs created page Category:Amino acids (Created page with "{{Commons category}} {{Cat main|Amino acid}} An '''amino acid''' is any molecule that contains both amino and carboxylic acid functional groups. Category:Amines Category:Carboxylic acids Category:Biomolecules by chemical classification Category:Amphoteric compounds")
- 10:06, 29 March 2024 Fire talk contribs created page Template:Catecholamine and trace amine biosynthesis/ja (Created page with "{{Annotated image 4 | caption = {{{caption|ヒトでは、カテコールアミンとフェネチルアミン作動性の微量アミンはアミノ酸{{nowrap|L-フェニルアラニン}}に由来する。}}} | header_background = {{{headerbg|#F0F8FF}}} | header = {{{header|ヒトの脳におけるカテコールアミンとtrace amine/ja|微量アミ...")
- 10:02, 29 March 2024 Fire talk contribs created page Template:If pagename (Redirected page to Template:When pagename is) Tag: New redirect
- 10:02, 29 March 2024 Fire talk contribs created page Template:Catecholamine and trace amine biosynthesis (Created page with "{{Annotated image 4 | caption = {{{caption|In humans, catecholamines and phenethylaminergic trace amines are derived from the amino acid {{nowrap|L-phenylalanine}}.}}} | header_background = {{{headerbg|#F0F8FF}}} | header = {{{header|Biosynthetic pathways for catecholamines and trace amines in the human brain<ref name="Trace amine template 1">{{cite journal | vauthors = Broadley KJ | title = The vascular effects of trace amines a...")
- 10:01, 29 March 2024 Fire talk contribs created page Template:Amino acid classification/ja (Created page with "{{flatlist|style=font-size:88%;|1= * '''Amino acids/jaタイプ''': コード化(タンパク質) * 必須 * 非タンパク質性 * ケトジェニック * 糖原性 * 第二アミノ酸 * イミノ酸 * D-amino acids/ja * [[Dehydroamino acid/ja]...")
- 09:59, 29 March 2024 Fire talk contribs created page Template:Amino acid classification (Created page with "{{flatlist|style=font-size:88%;|1= * '''Amino acids types''': Encoded (proteins) * Essential * Non-proteinogenic * Ketogenic * Glucogenic * Secondary amino * Imino acids * D-amino acids * Dehydroamino acids }}<noinclude> Category:Biochemistry templates </noinclude>")
- 09:49, 29 March 2024 Fire talk contribs created page Template:Protein primary structure/ja (Created page with "{{Navbox |name = Protein primary structure/ja |title=Protein primary structure/jaとposttranslational modification/ja |listclass = hlist | state = {{{state|autocollapse}}} |group1= 一般 |list1= * Peptide bond/ja * Protein biosynthesis/ja * Proteolysis/ja * Racemization/ja * N–O acyl shift/ja |group2= N terminus/ja |list2= * Acetylation/ja * Carbamylation/ja * Formylation/ja * Glycation/ja * Methylationja * Myr...")
- 09:41, 29 March 2024 Fire talk contribs created page Template:Protein primary structure (Created page with "{{Navbox |name = Protein primary structure |title=Protein primary structure and posttranslational modifications |listclass = hlist | state = {{{state|autocollapse}}} |group1= General |list1= * Peptide bond * Protein biosynthesis * Proteolysis * Racemization * N–O acyl shift |group2= N terminus |list2= * Acetylation * Carbamylation * Formylation * Glycation * Methylation * Myristoylation (Gly) |group3= C ter...")
- 09:41, 29 March 2024 Fire talk contribs created page Template:Chemical bonds/ja (Created page with "{{Navbox | name = Chemical bonds/ja | title = 化学結合 | listclass = hlist | image = 200px<br>200px<br>200px | group1 = 分子内<br/>(strong) | list1 = {{Navbox|subgroup | group1 = 共有 | list1 = *Electron deficiency/ja **3c–2e **Four-center...")
- 09:32, 29 March 2024 Fire talk contribs created page Template:Chemical bonds (Created page with "{{Navbox | name = Chemical bonds | title = Chemical bonds | listclass = hlist | image = 200px<br>200px<br>200px | group1 = Intramolecular<br/>(strong) | list1 = {{Navbox|subgroup | group1 = Covalent | list1 = *Electron deficiency **3c–2e **Four-center two-electron bond|4c...")
- 09:32, 29 March 2024 Fire talk contribs created page Template:Amino acids/ja (Created page with "{{Navbox |name = Proteinogenic amino acids/ja |bodyclass = hlist |title = コード化された(タンパク質生成)アミノ酸 |image=182px |group1 = 一般トピック |list1 = * タンパク質 * Peptide/ja * Genetic code/ja |group2 = プロパティ別 |list2 = {{Navbox|subgroup |group1 = 脂肪族 |list1 = * Branched-chain amino acid/ja (Valine/ja * [...")
- 09:29, 29 March 2024 Fire talk contribs created page Template:Amino acids (Created page with "{{Navbox |name = Proteinogenic amino acids |bodyclass = hlist |title = Encoded (proteinogenic) amino acids |image=182px |group1 = General topics |list1 = * Protein * Peptide * Genetic code |group2 = By properties |list2 = {{Navbox|subgroup |group1 = Aliphatic |list1 = * Branched-chain amino acids (Valine * Isoleucine * Leucine) * Methionine * Alanine...")
- 09:28, 29 March 2024 Fire talk contribs created page Amino acid (Created page with "{{short description|Organic compounds containing amine and carboxylic groups}} {{About|the class of chemicals|the structures and properties of the standard proteinogenic amino acids|Proteinogenic amino acid}} thumb|Structure of a typical <small>L</small>-alpha-amino acid in the "neutral" form. '''Amino acids''' are organic compounds that contain both amino and carboxylic acid functional groups. Although over 500 amino...")
- 08:36, 29 March 2024 Fire talk contribs created page Diabetic kidney disease/ja (Redirected page to 糖尿病性腎症) Tag: New redirect
- 08:36, 29 March 2024 Fire talk contribs created page Diabetic kidney disease (Redirected page to Diabetic nephropathy) Tag: New redirect
- 08:32, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/19/ja (Created page with "また、テルミサルタンはPPAR-γアゴニスト活性を有する。")
- 08:32, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/18/ja (Created page with "テルミサルタンのルオキシソーム増殖剤活性化受容体デルタ(PPAR-δ)受容体に対する活性は、GW 501516に代わるスポーツドーピング剤としての可能性を推測させる。テルミサルタンはいくつかの組織でPPAR-δ受容体を活性化する。")
- 08:32, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/17/ja (Created page with "テルミサルタンは、レニン-アンジオテンシン系を遮断するだけでなく、インスリンおよびグルコース代謝の中心的調節因子であるペルオキシソーム増殖因子活性化受容体γ(PPAR-γ)の選択的調節因子としても作用する。テルミサルタンの二重の作用機序は、diabete...")
- 08:31, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/16/ja (Created page with "===作用機序=== テルミサルタンはアンジオテンシンⅡ受容体遮断薬であり、アンジオテンシンⅡ受容体1型(AT<sub>1</sub>)に対して高い親和性を示し、AT<sub>1</sub>に対する結合親和性はAT<sub>2</sub>の3000倍である。")
- 08:19, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/15/ja (Created page with "==薬理学== {{Anchor|Pharmacology}}")
- 08:18, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/14/ja (Created page with "その作用機序により、テルミサルタンは血中カリウム濃度を上昇させる。カリウム製剤またはカリウム温存利尿薬との併用は、高カリウム血症(過剰なカリウム濃度)を引き起こす可能性がある。NSAIDsとの併用は、特に腎機能が低下している患者では、(通常は可逆的な)腎不全を...")
- 08:02, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/13/ja (Created page with "== 相互作用 == {{Anchor|Interactions}}")
- 08:02, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/12/ja (Created page with "==副作用== {{Anchor|Side effects}} 副作用は他のアンジオテンシンII受容体拮抗薬と同様であり、頻脈および徐脈(心拍が速いまたは遅い)、低血圧(血圧が低い)、および浮腫(腕、脚、唇、舌、または喉の腫れ、後者は呼吸障害につながる)が含まれる。アレルギー反応も起こることが...")
- 07:51, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/11/ja (Created page with "==禁忌== {{Anchor|Contraindications}} テルミサルタンは妊娠中には禁忌である。レニン-アンジオテンシン系(RAS)に影響を及ぼす他の薬物と同様に、テルミサルタンは先天異常、死産、新生児死亡を引き起こす可能性がある。薬物が母乳中に移行するかどうかは不明である。ま...")
- 07:50, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/10/ja (Created page with "==医薬用途== {{Anchor|Medical uses}} テルミサルタンは、高血圧、心不全、糖尿病性腎疾患の治療に用いられる。高血圧の初期治療としては妥当である。")
- 07:37, 29 March 2024 Fire talk contribs created page Translations:Telmisartan/20/ja (Created page with "===薬物動態=== この物質は腸から速やかに、しかし程度の差こそあれ吸収される。平均バイオアベイラビリティは約50%(42~100%)である。食物摂取はテルミサルタンの動態に臨床的に関連する影響を与えない。血漿蛋白結合率は99.5%以上で、主にアルブミンとα-1-酸性糖蛋白に...")
- 16:10, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/21/ja (Created page with "== 歴史 == {{Anchor|History}} {{see also/ja|Discovery and development of angiotensin receptor blockers/ja}}")
- 16:09, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/23/ja (Created page with "テルミサルタンはジェネリック医薬品として販売されている。")
- 16:09, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/22/ja (Created page with "==社会と文化== {{Anchor|Society and culture}}")
- 16:09, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/24/ja (Created page with "== さらに読む == * {{cite journal | vauthors = Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C | display-authors = 6 | title = Telmisartan, ramipril, or both in patients at high risk for vascular events | journal = The New England Journal of Medicine | volume = 358 | issue = 15 | pages = 1547–59 | date = April 2008 | pmid = 18378520 | doi = 10.1056/nejmoa0801317 | publisher = Massachusetts Medical Society | hdl = 2437/8...")
- 16:09, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/25/ja (Created page with "{{Agents acting on the renin–angiotensin system/ja}} {{Navboxes | title = Pharmacodynamics/ja | titlestyle = background:#ccccff | list1 = {{Angiotensin receptor modulators/ja}} {{PPAR modulators/ja}} {{Xenobiotic-sensing receptor modulators/ja}} }} {{Portal bar | Medicine}}")
- 16:08, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/26/ja (Created page with "Category:Angiotensin II receptor antagonists Category:Benzimidazoles Category:Benzoic acids Category:Biphenyls Category:Drugs developed by Boehringer Ingelheim Category:PPAR agonists Category:Wikipedia medicine articles ready to translate")
- 16:08, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/9/ja (Created page with "<!-- Society and culture --> テルミサルタンは1991年に特許を取得し、1999年に医薬品として使用されるようになった。ジェネリック医薬品として販売されている。2021年には、1{{nbsp}}万件以上の処方で、米国で217番目に多く処方された医薬品であった。")
- 16:08, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/8/ja (Created page with "<!-- Side effects and mechanisms --> 一般的な副作用には、上気道感染症、下痢、背部痛などがある。重篤な副作用としては、腎障害、低血圧、血管浮腫などがある。妊娠中の使用は赤ちゃんに害を及ぼす可能性があり、授乳中の使用は推奨されない。a...")
- 16:06, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/7/ja (Created page with "<!-- Definition and medical uses --> '''テルミサルタン'''('''Telmisartan''')は、とりわけ、'''ミカルディス'''という商品名で販売されており、高血圧、心不全、糖尿病性腎臓病の治療に用いられる医薬品である。高血圧の初期治療として妥当である。経口で服用する。 telmisartan/hydrochlorothiazide/ja|...")
- 16:04, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/6/ja (Created page with "<!-- Chemical data --> | IUPAC_name = 2-(4-<nowiki/>{[4-Methyl-6-(1-methyl-1''H''-1,3-benzodiazol-2-yl)-2-propyl-1''H''-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid | C=33 | H=30 | N=4 | O=2 | smiles = O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(c4nc3CCC)C)c5nc6ccccc6n5C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5...")
- 16:04, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/5/ja (Created page with "<!-- Identifiers --> | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 144701-48-4 | PubChem = 65999 | IUPHAR_ligand = 592 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00966 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 59391 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = U5SYW473RQ | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D00627 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 9434 | ChEMBL_Ref = {{ebicite|c...")
- 16:04, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/4/ja (Created page with "<!-- Pharmacokinetic data --> | bioavailability = 42–100% | protein_bound = >99.5% | metabolism = 最小限の肝臓(グルクロン酸化) | elimination_half-life = 24時間 | excretion = 糞中97%")
- 16:03, 28 March 2024 Fire talk contribs created page Telmisartan/ja (Created page with "<!-- Clinical data --> | pronounce = {{IPAc-en|t|ɛ|l|m|ɪ|ˈ|s|ɑr|t|ən}} | tradename = ミカルディス, アクタビス, その他 | Drugs.com = {{drugs.com|monograph|telmisartan}} | MedlinePlus = a601249 | DailyMedID = Telmisartan | pregnancy_AU = D | routes_of_administration = By mouth | class = Angiotensin II receptor antagonist/ja | ATC_prefix = C09 | ATC_suffix = CA07") Tags: Mobile edit Mobile web edit
- 16:03, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/3/ja (Created page with "| legal_AU = S4 | legal_CA = Rx-only | legal_CA_comment = | legal_UK = POM | legal_US = RX-only | legal_EU = RX-only")
- 16:03, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/2/ja (Created page with "<!-- Clinical data --> | pronounce = {{IPAc-en|t|ɛ|l|m|ɪ|ˈ|s|ɑr|t|ən}} | tradename = ミカルディス, アクタビス, その他 | Drugs.com = {{drugs.com|monograph|telmisartan}} | MedlinePlus = a601249 | DailyMedID = Telmisartan | pregnancy_AU = D | routes_of_administration = By mouth | class = Angiotensin II receptor antagonist/ja | ATC_prefix = C09 | ATC_suffix = CA07")
- 16:03, 28 March 2024 FuzzyBot talk contribs created page Telmisartan/en (Updating to match new version of source page)
- 16:03, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/1/ja (Created page with "{{Drugbox | Watchedfields = changed | verifiedrevid = 477861448 | image = Telmisartan.svg | width = 220 | alt =")
- 16:03, 28 March 2024 Fire talk contribs created page Translations:Telmisartan/Page display title/ja (Created page with "テルミサルタン")
- 16:02, 28 March 2024 FuzzyBot talk contribs created page Translations:Telmisartan/26/en (Importing a new version from external source)
- 16:02, 28 March 2024 FuzzyBot talk contribs created page Translations:Telmisartan/25/en (Importing a new version from external source)
- 16:02, 28 March 2024 FuzzyBot talk contribs created page Translations:Telmisartan/24/en (Importing a new version from external source)
- 16:02, 28 March 2024 FuzzyBot talk contribs created page Translations:Telmisartan/23/en (Importing a new version from external source)
- 16:02, 28 March 2024 FuzzyBot talk contribs created page Translations:Telmisartan/22/en (Importing a new version from external source)